| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769179 | Actas Urológicas Españolas | 2017 | 6 Pages |
Abstract
Our data suggest that the use of SBRT in carefully selected patients with metastatic oligorecurrence of prostate cancer can achieve biochemical response and potentially delay progression and the use of systemic treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
C. González Ruiz de León, M. RamÃrez Backhaus, M. Sobrón Bustamante, J. Casaña, L. Arribas, J. Rubio-Briones,